SUVEN PHARMACEUTICALS
|
The Current P/S Ratio of SUVEN PHARMACEUTICALS is 27.84.
Share Price | ₹1,146.7 | Apr 28,2025 |
Market Cap | ₹29,193.7 Cr | |
Sales-TTM | ₹1,048.5 Cr | TTM-Consolidated Results |
Price/Sales | 27.84x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of SUVEN PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹29,193.7 Cr] as on Apr 28,2025
(/) Sales [ ₹1,048.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 27.84x ]
Thus, for SUVEN PHARMACEUTICALS , the investors are currently willing to pay '27.84 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUVEN PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of SUVEN PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of SUVEN PHARMACEUTICALS
PS Ratio Performance Analysis for SUVEN PHARMACEUTICALS
- SUVEN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 10.57x.
- SUVEN PHARMACEUTICALS 's operated at median p/e ratio of 11.92x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUVEN PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 16.38x.
- SUVEN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 3.08x.
How does SUVEN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
SUVEN PHARMACEUTICALS | 1,048.5 | 27.84 | 29,193.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 8.56 | 441,910.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 17.63 | 160,035.0 |
CIPLA LTD | 26,981.2 | 4.65 | 125,540.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.99 | 112,894.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.21 | 100,110.0 |
MANKIND PHARMA LTD | 11,641.0 | 9.07 | 105,587.0 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.01 | 89,137.2 |
LUPIN LTD | 22,001.6 | 4.37 | 96,241.1 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.34 | 72,411.4 |
ABBOTT INDIA LTD | 6,243.2 | 10.13 | 63,214.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUVEN PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.34x |
Max industry PS | 27.84x |
Median industry PS | 8.56x |
Average industry PS | 9.25x |
You may also like the below Video Courses